Ethiopian Lives
-
NaaS Technology Maintains Strong ESG Momentum with '2' Rating and Improved Entity Score from Sustainable FitchDetails
BEIJING,Dec. 12,2024-- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company inChina,today announced that Sustainable Fitc
-
Tech Trends That WON'T Happen in 2025: AI-RAN, Consumer Smart Glasses, Humanoids, and Semiconductor Onshoring - To Name a FewDetails
ABI Research\'s 5th annual Trend Report identifies the 53 key technology trends that will come to fruition—and the 48 that won\'t—in 2025
-
aiMotive collaborates with Sony Semiconductor Solutions to revolutionize AD simulationsDetails
BUDAPEST,Hungary,Dec. 12,2024--aiMotive,a leading developer of simulation and AI solutions for automated driving technology,in collaboration withSony Semiconductor Solutions Corporation (Sony),a glob
-
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine CandidateDetails
SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.
-
Ascenda Partners with Cardless to Transform Co-Brand Landscape and Enable New Loyalty OpportunitiesDetails
NEW YORK,Dec. 12,2024-- Ascenda,the industry leader in loyalty as a service,today announced a strategic partnership with Cardless,a digital-first credit card platform,aimed at transforming the co-bra
-
Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025Details
The groundbreaking display projects critical driving information across the entire width of the windshield,offering a panoramic and immersive experience that spans from the driver\'s seat to the pass
-
Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG HospitalDetails
- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY,Vietnam,Dec. 12,2024-- Core8 Group,an Australian leader in high-tech and biotech innovation,has unveile
-
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver MetastasisDetails
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
-
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet TherapyDetails
SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir
-
Abu Dhabi Sustainable Finance Forum Marks the Conclusion of ADFW 2024Details
ABU DHABI,UAE,Dec. 12,2024-- ADGM,the international financial centre (IFC) of Abu Dhabi,in partnership with Global Climate Finance Centre (GCFC),HSBC and Smartenergy,today hosted the 7th edition of t